Incidence of neuropathy with weekly paclitaxel and role of oral glutamine supplementation for prevention of paclitaxel induced peripheral neuropathy randomized controlled trial
Background: Peripheral neuropathy is damage to the peripheral nerve. The most common cause of neuropathy is paclitaxel. Several avenues have been explored to ameliorate the neurotoxicity associated with paclitaxel. Clinical studies have assessed the efficacy of glutamine with different doses and sch...
| Published in: | Indian Journal of Medical and Paediatric Oncology |
|---|---|
| Main Authors: | Waseem Abbas, Ranga Raju Rao, Amit Agarwal, Rajat Saha, Peush Bajpai, Suhail Qureshi, Aditi Mittal |
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018-01-01
|
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=3;spage=339;epage=348;aulast=Abbas |
Similar Items
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)
by: Ines Klein, et al.
Published: (2021-09-01)
Activating autophagy improves paclitaxel-induced peripheral neuropathy in chemotherapy
by: Jin Zhang, et al.
Published: (2024-10-01)
by: Jin Zhang, et al.
Published: (2024-10-01)
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)
Paclitaxel-induced neuropathy induces changes in oral cavity organs of rats
by: A. A. Kotvytska, et al.
Published: (2023-02-01)
by: A. A. Kotvytska, et al.
Published: (2023-02-01)
Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Mariko Ezaka, et al.
Published: (2022-10-01)
by: Mariko Ezaka, et al.
Published: (2022-10-01)
Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
by: Su-Hyun Kim, et al.
Published: (2022-08-01)
by: Su-Hyun Kim, et al.
Published: (2022-08-01)
The correlation between vitamin D and the occurrence of peripheral neuropathy induced by paclitaxel chemotherapy
by: Jialei Zhang, et al.
Published: (2024-09-01)
by: Jialei Zhang, et al.
Published: (2024-09-01)
Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
by: Su-Hyun Kim, et al.
Published: (2023-09-01)
by: Su-Hyun Kim, et al.
Published: (2023-09-01)
Evaluation of the Safety and Efficacy of N-acetylcysteine in the Prevention of Paclitaxel-induced Peripheral Neuropathy: A Randomized, Double-blind, and Placebo-controlled Trial
by: Sima Ramezaninejad, et al.
Published: (2025-01-01)
by: Sima Ramezaninejad, et al.
Published: (2025-01-01)
Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy
by: Zizhen Wu, et al.
Published: (2022-12-01)
by: Zizhen Wu, et al.
Published: (2022-12-01)
A novel isoquinoline mitophagy inducer ameliorates paclitaxel-induced peripheral neuropathy in Drosophila and mouse models
by: Sangwoo Im, et al.
Published: (2025-07-01)
by: Sangwoo Im, et al.
Published: (2025-07-01)
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients
by: Jörn Lötsch, et al.
Published: (2024-09-01)
by: Jörn Lötsch, et al.
Published: (2024-09-01)
Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
by: Milda Girdenytė, et al.
Published: (2024-11-01)
by: Milda Girdenytė, et al.
Published: (2024-11-01)
The Antinociceptive Responses of MTDZ to Paclitaxel−Induced Peripheral Neuropathy and Acute Nociception in Mice: Behavioral, Pharmacological, and Biochemical Approaches
by: Ketlyn P. da Motta, et al.
Published: (2023-08-01)
by: Ketlyn P. da Motta, et al.
Published: (2023-08-01)
Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions
by: Aalaa Mahmoud Ahmed Shawqi Mahmoud, et al.
Published: (2024-05-01)
by: Aalaa Mahmoud Ahmed Shawqi Mahmoud, et al.
Published: (2024-05-01)
Management of paclitaxel-induced neurotoxicity
by: Manisha Bhutani, et al.
Published: (2011-12-01)
by: Manisha Bhutani, et al.
Published: (2011-12-01)
Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy
by: Anthony M. Cirrincione, et al.
Published: (2022-05-01)
by: Anthony M. Cirrincione, et al.
Published: (2022-05-01)
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
by: Junji Tsurutani, et al.
Published: (2021-02-01)
by: Junji Tsurutani, et al.
Published: (2021-02-01)
Electroacupuncture alleviates paclitaxel-induced peripheral neuropathy by reducing CCL2-mediated macrophage infiltration in sensory ganglia and sciatic nerve
by: Yuanyuan Li, et al.
Published: (2025-01-01)
by: Yuanyuan Li, et al.
Published: (2025-01-01)
Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine
by: David Balayssac, et al.
Published: (2023-12-01)
by: David Balayssac, et al.
Published: (2023-12-01)
Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial
by: Haruru Kotani, et al.
Published: (2021-05-01)
by: Haruru Kotani, et al.
Published: (2021-05-01)
Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study
by: Tomoyoshi Miyamoto, et al.
Published: (2021-05-01)
by: Tomoyoshi Miyamoto, et al.
Published: (2021-05-01)
Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study
by: Sun Lixian, et al.
Published: (2024-03-01)
by: Sun Lixian, et al.
Published: (2024-03-01)
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
by: Hong-Xiang Shi, et al.
Published: (2024-07-01)
by: Hong-Xiang Shi, et al.
Published: (2024-07-01)
Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
by: Hichem Bouchenaki, et al.
Published: (2022-04-01)
by: Hichem Bouchenaki, et al.
Published: (2022-04-01)
Paclitaxel effects on axonal localization and vesicular trafficking of NaV1.8
by: Christopher A. Baker, et al.
Published: (2023-02-01)
by: Christopher A. Baker, et al.
Published: (2023-02-01)
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
by: Hana Starobova, et al.
Published: (2017-05-01)
by: Hana Starobova, et al.
Published: (2017-05-01)
Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice
by: Natsuki Kato, et al.
Published: (2020-12-01)
by: Natsuki Kato, et al.
Published: (2020-12-01)
The PINK1 Activator Niclosamide Mitigates Mitochondrial Dysfunction and Thermal Hypersensitivity in a Paclitaxel-Induced <i>Drosophila</i> Model of Peripheral Neuropathy
by: Hye-Ji Jang, et al.
Published: (2022-04-01)
by: Hye-Ji Jang, et al.
Published: (2022-04-01)
The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
by: Primandono Perbowo, et al.
Published: (2019-07-01)
by: Primandono Perbowo, et al.
Published: (2019-07-01)
Evaluation of the effect of pentoxifylline on the prevention of paclitaxel‑induced peripheral neuropathy in breast cancer patients: a randomized controlled study
by: Sondos S. Saleh, et al.
Published: (2024-10-01)
by: Sondos S. Saleh, et al.
Published: (2024-10-01)
Pia Mater‐Penetrable Lipopolymer Nanoparticles for Gliocyte‐Targeted IL‐10 mRNA Therapy Alleviate Paclitaxel‐Induced Peripheral Neuropathy
by: Xinrou Lin, et al.
Published: (2025-06-01)
by: Xinrou Lin, et al.
Published: (2025-06-01)
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel
by: Guido Cavaletti, et al.
Published: (2025-09-01)
by: Guido Cavaletti, et al.
Published: (2025-09-01)
The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy
by: Kubilay Karaboyun, et al.
Published: (2023-11-01)
by: Kubilay Karaboyun, et al.
Published: (2023-11-01)
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial
by: Chikako Funasaka, et al.
Published: (2023-07-01)
by: Chikako Funasaka, et al.
Published: (2023-07-01)
Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
by: Kohei Mori, et al.
Published: (2022-11-01)
by: Kohei Mori, et al.
Published: (2022-11-01)
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
by: Hiroaki Tanioka, et al.
Published: (2019-10-01)
by: Hiroaki Tanioka, et al.
Published: (2019-10-01)
Role of neuron-derived ATP in paclitaxel-induced HMGB1 release from macrophages and peripheral neuropathy
by: Risa Domoto, et al.
Published: (2022-01-01)
by: Risa Domoto, et al.
Published: (2022-01-01)
Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
by: Fei-ze Wu, et al.
Published: (2018-08-01)
by: Fei-ze Wu, et al.
Published: (2018-08-01)
Upregulation of NGF/TrkA-Related Proteins in Dorsal Root Ganglion of Paclitaxel-Induced Peripheral Neuropathy Animal Model
by: Kim Y, et al.
Published: (2024-11-01)
by: Kim Y, et al.
Published: (2024-11-01)
Similar Items
-
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01) -
Activating autophagy improves paclitaxel-induced peripheral neuropathy in chemotherapy
by: Jin Zhang, et al.
Published: (2024-10-01) -
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01) -
Paclitaxel-induced neuropathy induces changes in oral cavity organs of rats
by: A. A. Kotvytska, et al.
Published: (2023-02-01) -
Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Mariko Ezaka, et al.
Published: (2022-10-01)
